[Form 4] Inspire Veterinary Partners, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kimball Carr, Chief Executive Officer, President and Chair acquired 92,593 Class A common shares by exercising stock options with a $1.62 exercise (conversion) price on 05/16/2025. The options were exercisable on 05/16/2025 and expire 05/16/2035. Following the reported transaction, 92,593 shares are beneficially owned directly. Remarks state the Form 4 was filed late due to an inadvertent administrative error.

Positive

• Insider acquisition: CEO Kimball Carr acquired 92,593 Class A common shares by exercising stock options.
• Transparent transaction details: Exercise price ($1.62), exercisable date (05/16/2025) and expiration date (05/16/2035) are disclosed.

Negative

• Late filing: Remarks state the Form 4 was filed late due to an inadvertent administrative error.

Insights

Corporate Governance Expert

TL;DR: CEO exercised options for 92,593 shares; transaction is routine but the late filing raises a governance disclosure lapse.

The reporting shows a non-derivative acquisition via exercise of stock options converting into 92,593 Class A shares at a $1.62 conversion price, exercisable immediately and expiring in 2035. The filing discloses direct beneficial ownership of 92,593 shares. The remarks note the Form 4 was filed late due to an inadvertent administrative error, which is a disclosure control matter investors and governance committees typically monitor.

Securities Analyst

TL;DR: Insider exercise of 92,593 options at $1.62 is a factual ownership change; impact on capitalization depends on outstanding shares.

The report documents a stock option exercise converting to 92,593 shares of Class A common stock at a $1.62 exercise price, with exercisability and expiration dates provided. The transaction increases the reporting persons direct holdings by 92,593 shares. The filing being late is noted in the remarks; no other material operational or financial information is included in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carr Kimball

(Last) (First) (Middle)

780 LYNNHAVEN PARKWAY

SUITE 400

(Street)

VIRGINIA BEACH VA 23452

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
05/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.62	05/16/2025		A		92,593		05/16/2025	05/16/2035	Class A Common Stock	92,593	$0	92,593	D

Explanation of Responses:

Remarks:

Chief Executive Officer, President and Chair of Board. This Form 4 is being filed late due to inadvertent administrative error.

	/s/ Kimball Carr	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Kimball Carr report on the IVP Form 4?

He exercised stock options to acquire 92,593 Class A common shares at a $1.62 exercise (conversion) price.

What role does Kimball Carr hold at Inspire Veterinary Partners (IVP)?

He is listed as Chief Executive Officer, President and Chair of the Board.

When were the options exercised and when do they expire?

The transaction date and exercisable date are 05/16/2025; the options expire on 05/16/2035.

How many shares does Kimball Carr beneficially own following the transaction?

Following the reported transaction, he beneficially owns 92,593 shares directly.

Was the Form 4 filing timely?

No. The remarks state the Form 4 was filed late due to an inadvertent administrative error.